|
Handok Pharmaceuticals Co., Ltd. - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Handok Pharmaceuticals Co., Ltd.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Handok Pharmaceuticals Co., Ltd.. The Company's principal activities are manufacturing and distributing over-the-counter medicines. The Company's products include Amaryl for diabetes, Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular disease, Teveten for essential hypertension, Festal for dyspepsia, Munobal for hypertension and stenocardia, Triapin for essential hypertension, Gatiflo for respiratory and other infective disease, Lasix for hypertension and edema, Ketas for disturbance of cerebral circulation and Dermatop for dermatology. In addition, the Company offers reagents and diagnostic instruments. It is also engaged in the real estate leasing business. The Company operates a research laboratory in Seoul and a plant in Chungcheongbuk-Do, Korea.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|